Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care

Published:2016-09-26 Issue:11 Volume:33 Page:2049-2058
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Colivicchi Furio,Gulizia Michele Massimo,Franzini Laura,Imperoli Giuseppe,Castello Lorenzo,Aiello Alessandro,Ripellino Claudio,Cataldo Nazarena

Funder

AstraZeneca (IT)

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-016-0412-8.pdf

Reference28 articles.

1. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55.000 vascular deaths. Lancet. 2007;370:1829–39.

2. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Lancet. 2005; 366:1267–78.

3. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170.000 participants in 26 randomised trials. Lancet 2010; 376:1670–81.

4. ESC/EAS Guidelines for the management of dyslipidaemias. the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769–818.

5. Adams SP, Sekhon SS, Wright JM. Lipid-lowering efficacy of rosuvastatin. Cochrane Database Syst Rev. 2014; 11:CD010254.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The problem of choice: original drug or generic? Emphasis on rosuvastatin;Rational Pharmacotherapy in Cardiology;2022-05-06

2. The problem of choice: original drug or generic? Emphasis on rosuvastatin;RATION PHARMACOTHER;2022

3. Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study;International Journal of Antimicrobial Agents;2020-07

4. What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis;Respiratory Medicine;2020-05

5. Differences in drug use between men and women: an Italian cross sectional study;BMC Women's Health;2017-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3